Literature DB >> 7627652

Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits.

B F Johnson1, L Evans, R Drury, D Datta, W Morris-Jones, J D Beard.   

Abstract

OBJECTIVES: To study the quality of life of patients following surgery for critical limb is ischaemia.
DESIGN: Part retrospective, part prospective open study.
SETTING: Vascular unit of a University Hospital. MATERIALS: Seventy-nine consecutive patients, medium age 75 years (range 44 to 94), who presented with leg threatening ischaemia and who underwent successful revascularisation or a major amputation were studied. CHIEF OUTCOME MEASURES: Six separate quality of life measures were recorded at 6 months: pain, mobility, anxiety, depression, activities of daily living (Barthel) and lifestyle (Frenchay). MAIN
RESULTS: The mortality of this group of patients after six months was 24%. Forty-seven patients were available for quality of life assessment six months after initial intervention. Overall, amputation was more costly than successful revascularisation and limb salvage. Limb salvage resulted in greater mobility (p < 0.001) and better performance in self-care (p < 0.001) and lifestyle (p = 0.006), but produced more anxiety and depression (p = 0.04) than major amputation. A subgroup of patients who had major amputation after a failed limb salvage operation consumed a disproportionate amount of resources and, although their mobility was typical of amputees, their self-care and lifestyle scores were similar to those who had successful limb salvage. OBSTRUCTIONS: Limb salvage is attempted in up to 22% of patients for whom primary amputation may provide more expeditious rehabilitation with minimal impairment of their lifestyle performance.

Entities:  

Mesh:

Year:  1995        PMID: 7627652     DOI: 10.1016/s1078-5884(05)80088-7

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  5 in total

Review 1.  The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.

Authors:  M Deverill; J Brazier; C Green; A Booth
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 2.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

3.  Costs of deep foot infections in patients with diabetes mellitus.

Authors:  G R Tennvall; J Apelqvist; M Eneroth
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

4.  Tibial nerve decompression for the prevention of the diabetic foot: a cost-utility analysis using Markov model simulations.

Authors:  Samuel Sarmiento; James A Pierre; A Lee Dellon; Kevin D Frick
Journal:  BMJ Open       Date:  2019-03-15       Impact factor: 2.692

5.  Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan.

Authors:  Qusai Aljarrah; Sohail Bakkar; Abdelwahab Aleshawi; Omar Al-Gharaibeh; Mooath Al-Jarrah; Radi Ebwayne; Mohammed Allouh; Ahmad K Abou-Foul
Journal:  Clinicoecon Outcomes Res       Date:  2020-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.